Entecavir to TAF Switch
NCT03489239
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B
Interventions
DRUG:
Tenofovir Alafenamide
Sponsor
Thomas Jefferson University
Collaborators
[object Object]